Mary Jo Petras, MA CCCA FAAA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 721 Sheridan Ave, Suite 150 Big Horn Basin Hearing Inc, Cody, WY 82414 Phone: 307-527-6475 Fax: 307-527-6483 |
Ben Joseph Koperski, MA CCCA FAAA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 721 Sheridan Ave, Ste 150 Big Horn Basin Hearing Inc, Cody, WY 82414 Phone: 307-527-6475 Fax: 307-527-6483 |
Mrs. Brandi R Shepard, CCC-A, F-AAA Audiologist Medicare: Accepting Medicare Assignments Practice Location: 424 Yellowstone Ave Ste 310, Cody, WY 82414 Phone: 307-578-2976 Fax: 307-578-2941 |
Big Horn Basin Hearing Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 721 Sheridan Ave, Ste 150 Big Horn Basin Hearing Inc, Cody, WY 82414 Phone: 307-527-6475 Fax: 307-527-6483 |
Cody Audiology Clinic Audiologist Medicare: Medicare Enrolled Practice Location: 902 Blackburn St, Cody, WY 82414 Phone: 307-587-2707 |
News Archive
Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with PSX1002 in patients with moderate to severe chronic obstructive pulmonary disease.
A little extra sugar can make us crave just about anything, from cookies to condiments to coffee smothered in whipped cream. But its sweetness doesn't fully explain our desire. Instead, new research shows this magic molecule has a back channel to the brain.
Hospitalized COVID-19 patients in the U.S. are enduring longer hospital stays and facing higher rates of intensive care unit admission than patients in China, finds a new study led by researchers at the University of California, Berkeley, and Kaiser Permanente.
In patients with chronic obstructive pulmonary disease (COPD), exacerbations accelerated lung function loss, according to a new study presented at the ATS 2016 International Conference. The effect was particularly prominent in those with mild disease.
Pharmaceutical companies are finding innovative new strategies to retain market share after drug patent expiration. One of the most successful of these new strategies appears to be 'flanking.' Under this strategy, brand-name drug companies sign licensing agreements with their generic competitors to establish manufacturer- distributor relationships.
› Verified 5 days ago